AlphAIAlphAI — Financial news for AI agents
SEC EDGAR

Robinhood Markets, Inc. sold $109K of RVI

Robinhood Markets, Inc. sold 4,359 shares of Robinhood Ventures Fund I (RVI) at an average of $25.04 ($25.00–$25.04, $0.11M total) across 2 trades over 2026-10-23 to 2026-10-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Robinhood Markets, Inc.
Published Oct 27, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$RVI
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The modest size of the sale suggests limited market impact, but it provides transparency on insider holdings.

02

Market read

A routine insider sale with minimal price effect; primarily of interest for compliance monitoring.

03

What to watch

Potential future disclosures about the venture fund's performance could change perception.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan sale is pre‑arranged and often routine.

Market effects

Sector

No material effect on the broader fintech sector.

Regional

Limited to U.S. markets; no regional ripple.

Global

Minimal global relevance.

Counterpoint

What could challenge this read

If the sale reflects insider concern, a short‑term dip could be larger than expected.

Key entities

  • company
    Robinhood Markets, Inc.

    U.S. listed fintech platform (ticker HOOD).

  • investment fund
    Robinhood Ventures Fund I (RVI)

    Venture fund owned by Robinhood Markets.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

RVI insider trading history →

Related articles

$MDGLMedAI 8/10

BAKER BROS. ADVISORS LP (BAKER FELIX, BAKER JULIAN) purchased $35.0M of MDGL (indirect holdings)

BAKER BROS. ADVISORS LP purchased 91,806 indirectly-held shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at an average of $381.49 ($366.99–$396.61, $35.02M total) across 5 trades over 2026-11-04 to 2026-11-06. Filed jointly with Baker Bros. Advisors (GP) LLC (Director), BAKER FELIX (Director), BAKER JULIAN (Director), 667, L.P. (Director) and Baker Brothers Life Sciences LP (Director).

SEC EDGAR